TermGallery
Английский
Английский
Испанский
Каталонский
Португальский
Русский
RU
English
Español
Català
Português
Русский
A tumor in Homo sapiens.
human tumour
human tumour
1
In
human
tumours
,
DIAPH3 down-regulation was associated with aggressive or metastatic disease.
2
In
human
tumours
,
a number of different proteases also correlate with metastatic potential.
3
Recent evidence suggests that Runt-related transcription factors play a role in different
human
tumours
.
4
The tumour suppressor gene TP53 is the most frequently mutated gene in
human
tumours
.
5
Most
human
tumours
are heterogeneous, composed of cellular clones with different properties present at variable frequencies.
1
Intriguingly, however, VWF binding to specific
human
tumor
cell lines results in apoptosis.
2
The contribution of Th17 cells to
human
tumor
immunity, however, remains largely unknown.
3
The anticancer activity of carminomycin was investigated in a
human
tumor
cloning assay.
4
Our gene-expression studies in
human
tumor
samples revealed overexpression of PRKCI.
5
However, further investigations are required to develop novel immunological methods for
human
tumor
treatment.
6
However, its role in
human
tumor
development and on patient survival is not known.
7
Some
human
tumor
lines do not form visible tumors when inoculated into immunosuppressed mice.
8
The findings have very important implications in
human
tumor
immunotherapy.
9
We induced RNA degradation in
human
tumor
and healthy tissue samples by endogeneous ribonucleases.
10
At least seven such proteins were detected in extracts of multiple
human
tumor
cell lines.
11
Gemcitabine is a potent radiosensitizer of
human
tumor
cells.
12
It activates prodrugs and induces cytotoxicity in
human
tumor
cells but not in host bacteria.
13
The antitumor efficacy was assessed at equimolar doses in nude mice bearing
human
tumor
xenografts.
14
Furthermore, it causes growth inhibition of
human
tumor
xenografts in nude mice as a single agent.
15
Reconstitution of tumor development in immunodeficient mice from disaggregated primary
human
tumor
cells is always challenging.
16
These doses of AT7867 also resulted in inhibition of
human
tumor
growth in PTEN-deficient xenograft models.
human
tumor
human